{
 "PrintNo":"A9485","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2024-03-14T12:57:43.108641Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-03-14","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2024-03-14","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"}],
 "Title":"Relates to adding W-18 to the schedule of controlled substances",
 "Summary":"Adds W-18 (4-chloro-N-{1-{2-(4-nitrophenyl)ethyl}2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3306, Pub Health L",
 "PreviousVersions":["A3030-2017","A509-2019","A486-2021"]
}